DaVita Inc.
DVA
Xếp hạng trong cổ phiếu
#1897
DaVita Inc. specializes in delivering essential kidney dialysis treatments and... DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
Giá cổ phiếu
$174.82
Đồng bộ lần cuối: 2026-10-20
Vốn hóa thị trường
$11.15B
Thay đổi (1 ngày)
-6.61%
Thay đổi (1 năm)
36.14%
Quốc gia
US
Giao dịch DaVita Inc. (DVA)
Danh mục
Healthcare
Doanh thu của DaVita Inc. (DVA)
Doanh thu vào Jun 2026 TTM: $14.01B
Theo các báo cáo tài chính gần đây của DaVita Inc., doanh thu hiện tại của công ty (TTM) là $14.01B. Trong năm 2024, công ty đạt doanh thu $12.82B tăng so với doanh thu năm 2023, là $12.14B. Doanh thu là tổng số tiền công ty tạo ra từ việc bán hàng hóa hoặc dịch vụ. Không giống như lợi nhuận, doanh thu không trừ chi phí.
Lịch sử doanh thu của DaVita Inc. từ 2000 đến 2026
Doanh thu vào cuối mỗi năm
| Năm | Doanh thu | Thay đổi |
|---|---|---|
| 2026 (TTM) | $14.01B | 2.69% |
| 2025 | $13.64B | 6.46% |
| 2024 | $12.82B | 5.56% |
| 2023 | $12.14B | 4.57% |
| 2022 | $11.61B | -0.08% |
| 2021 | $11.62B | 0.59% |
| 2020 | $11.55B | 1.42% |
| 2019 | $11.39B | -0.14% |
| 2018 | $11.40B | 4.86% |
| 2017 | $10.88B | -26.24% |
| 2016 | $14.75B | 6.99% |
| 2015 | $13.78B | 7.71% |
| 2014 | $12.80B | 8.76% |
| 2013 | $11.76B | 43.70% |
| 2012 | $8.19B | 20.53% |
| 2011 | $6.79B | 5.34% |
| 2010 | $6.45B | 5.54% |
| 2009 | $6.11B | 7.93% |
| 2008 | $5.66B | 7.52% |
| 2007 | $5.26B | 7.86% |
| 2006 | $4.88B | 64.12% |
| 2005 | $2.97B | 29.38% |
| 2004 | $2.30B | 12.32% |
| 2003 | $2.05B | 10.34% |
| 2002 | $1.85B | 12.35% |
| 2001 | $1.65B | 11.06% |
| 2000 | $1.49B | 0.00% |
Doanh thu của các công ty hoặc đối thủ tương tự
| Công ty | Doanh thu | Chênh lệch doanh thu | Quốc gia |
|---|---|---|---|
| $78.01B | 456.85% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 55.69% |
US
|
|
| $3.89B | -72.20% |
SA
|
|
| $11.08B | -20.88% |
BR
|
